With the current operating strategy for phase II they need 30-40 people with a UTI to recruit and be treated. Stratify them into different dosing regimes. Path tests of a few days after. Independent review panel review 3 months. All done inside 8 months.
Phase III studies are likely to be much bigger, but seriously if you have sepsis secondary to a UTI you are dying without prompt effective treatment. You will take the treatment. If you are alive 3 days later the treatment worked. No long follow up. Lets say recruitment takes a year you are still done inside 18 months.
On top of this they will need probably another 6-9 months for the FDA to agree on trial design. Still on track.
- Forums
- ASX - By Stock
- RCE
- Ann: R327 added to WHO List of Antibacterial Products
Ann: R327 added to WHO List of Antibacterial Products, page-20
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
59.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.3M |
Open | High | Low | Value | Volume |
59.0¢ | 59.0¢ | 59.0¢ | $4.975K | 8.433K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 15377 | 57.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
59.5¢ | 40452 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 15377 | 0.575 |
3 | 8864 | 0.570 |
1 | 15000 | 0.565 |
4 | 32423 | 0.560 |
2 | 2901 | 0.555 |
Price($) | Vol. | No. |
---|---|---|
0.595 | 40452 | 3 |
0.600 | 50611 | 3 |
0.605 | 2000 | 1 |
0.650 | 78200 | 3 |
0.655 | 6970 | 1 |
Last trade - 10.12am 20/06/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
INF
INFINITY LITHIUM CORPORATION LIMITED
Ryan Parkin, Managing Director & CEO
Ryan Parkin
Managing Director & CEO
Previous Video
Next Video
SPONSORED BY The Market Online